サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：植え込み型心調律管理デバイスの世界市場 - 市場規模・シェア・動向分析：製品別（ペースメーカー、ICD、CRT）、最終用途別（病院、心臓専門センター）、地域別、セグメント別の予測（2022年～2030年）
市場調査レポート
商品コード
1076448

植え込み型心調律管理デバイスの世界市場 - 市場規模・シェア・動向分析：製品別（ペースメーカー、ICD、CRT）、最終用途別（病院、心臓専門センター）、地域別、セグメント別の予測（2022年～2030年）

Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End Use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
植え込み型心調律管理デバイスの世界市場 - 市場規模・シェア・動向分析：製品別（ペースメーカー、ICD、CRT）、最終用途別（病院、心臓専門センター）、地域別、セグメント別の予測（2022年～2030年）
出版日: 2022年04月18日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の植え込み型心調律管理デバイスの市場規模は、2030年までに289億米ドルに達し、2022年～2030年にCAGRで6.2％の成長が予測されています。

CVDにかかりやすい世界の高齢者人口の増加と、これらの疾患の正確かつ効果的な診断に対する需要の高まりが、植え込み型心調律管理（CRM）デバイスの成長を促す要因となっています。

当レポートでは、世界の植え込み型心調律管理デバイス市場について調査分析し、市場の動向、製品・最終用途・地域別の分析、競合分析などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 植え込み型心調律管理デバイス市場の変数・動向・範囲

  • 市場力学
  • 心調律管理デバイス：市場分析ツール

第4章 COVID-19影響分析

  • COVID-19有病率分析
  • 現在の影響と将来のシナリオ
  • 企業への影響

第5章 植え込み型心調律管理デバイス市場：セグメント分析、製品別（2017年～2030年）

  • 定義と範囲
  • 製品タイプの市場シェア分析（2021年・2030年）
  • 世界の植え込み型心調律管理デバイス市場：製品別（2017年～2030年）
  • 市場規模・予測・動向分析（2017年～2030年）
    • ペースメーカー
    • ICD
    • CRT

第6章 植え込み型心調律管理デバイス市場：セグメント分析、最終用途別（2017年～2030年）

  • 定義と範囲
  • 最終用途の市場シェア分析（2017年～2030年）
  • 世界の心調律管理デバイス市場：最終用途別（2017年～2030年）
  • 市場規模・予測・動向分析（2017年～2030年）
    • 病院
    • 心臓専門センター
    • その他

第7章 植え込み型心調律管理デバイス市場：地域市場分析、製品・最終用途別（2017年～2030年）

  • 定義と範囲
  • 地域市場シェア分析（2017年～2030年）
  • 地域市場スナップショット
  • 市場規模・予測・動向分析（2017年～2030年）
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 植え込み型心調律管理デバイス市場 - 競合分析

  • 市場参入企業の分類
    • 企業市況分析
    • シナジー分析：主要な取引と戦略的提携
    • マーケットリーダー
    • イノベーター
  • 主要企業のリスト

第9章 植え込み型心調律管理デバイス市場 - 企業プロファイル

  • Stryker
  • Schiller
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • Biotronik
  • Nihon Kohden Corporation
  • Microport Scientific Corporation
図表

List of Tables

  • Table 1 Global implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 2 Global implantable CRM devices market, by end use, 2017 - 2030
  • Table 3 Global implantable CRM devices market, by region, 2017 - 2030 (USD Million)
  • Table 4 North America implantable CRM devices market, by country, 2017 - 2030 (USD Million)
  • Table 5 North America implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 6 North America implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 7 U.S. implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 8 U.S. implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 9 Canada implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 10 Canada implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 11 Europe implantable CRM devices market, by country, 2017 - 2030 (USD Million)
  • Table 12 Europe implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 13 Europe implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 14 U.K. implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 15 U.K. implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 16 Germany implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 17 Germany implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 18 France implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 19 France implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 20 Italy implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 21 Italy implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 22 Spain implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 23 Spain implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 24 Asia Pacific implantable CRM devices market, by Country, 2017 - 2030 (USD Million)
  • Table 25 Asia Pacific implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 26 Asia Pacific implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 27 Japan implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 28 Japan implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 29 China implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 30 China implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 31 India implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 32 India implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 33 Australia implantable CRM devices market, by country, 2017 - 2030 (USD Million)
  • Table 34 Australia implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 35 Latin America implantable CRM devices market, by country, 2017 - 2030 (USD Million)
  • Table 36 Latin America implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 37 Latin America implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 38 Mexico implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 39 Mexico implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 40 Brazil implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 41 Brazil implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 42 MEA implantable CRM devices market, by country, 2017 - 2030 (USD Million)
  • Table 43 MEA implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 44 MEA implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 45 South Africa implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 46 South Africa implantable CRM devices market, by end use, 2017 - 2030 (USD Million)
  • Table 47 Saudi Arabia implantable CRM devices market, by product, 2017 - 2030 (USD Million)
  • Table 48 Saudi Arabia implantable CRM devices market, by end use, 2017 - 2030 (USD Million)

List of figures

Fig. 1 Implantable CRM devices market segmentation

Fig. 2 Market research process

Fig. 3 Information procurement

Fig. 4 Primary research pattern

Fig. 5 Market research approaches

Fig. 6 Value chain-based sizing & forecasting

Fig. 7 QFD modelling for market share assessment

Fig. 8 Implantable Cardiac Rhythm Management (CRM) devices market revenues, 2021, (USD Millions)

Fig. 9 Penetration & growth prospect mapping

Fig. 10 Market trends & outlook

Fig. 11 Porter's five forces analysis

Fig. 12 PESTLE analysis

Fig. 13 Strategy mapping

Fig. 14 Implantable CRM devices market product outlook:

Fig. 15 Implantable CRM devices market: Product movement analysis

Fig. 16 Segment dashboard

Fig. 17 Global pacemaker market, 2017 - 2030 (USD Million)

Fig. 18 Global ICDS market, 2017 - 2030 (USD Million)

Fig. 19 Global CRT market, 2017 - 2030 (USD Million)

Fig. 20 Implantable CRM devices market end-use outlook:

Fig. 21 Implantable CRM devices market: End-use movement analysis

Fig. 22 Global hospitals market, 2017 - 2030 (USD Million)

Fig. 23 Global specialty cardiac centers market, 2017 - 2030 (USD Million)

Fig. 24 Global others market, 2017 - 2030 (USD Million)

Fig. 25 Regional market place: Key takeaways

Fig. 26 North America implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 27 U.S. implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 28 Canada implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 29 Europe implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 30 Germany implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 31 U.K. implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 32 France implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 33 Italy implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 34 Spain implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 35 Asia Pacific implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 36 Japan implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 37 China implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 38 India implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 39 Australia implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 40 Latin America implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 41 Mexico implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 42 Brazil implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 43 MEA implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 44 South Africa implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 45 Saudi Arabia implantable CRM devices market, 2017 - 2030 (USD Million)

Fig. 46 Company market position analysis

目次
Product Code: GVR-2-68038-882-4

Implantable Cardiac Rhythm Management Devices Market Growth & Trends:

The global implantable cardiac rhythm management devices market size is expected to reach USD 28.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increasing global geriatric population prone to CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing to the growth of implantable cardiac rhythm management (CRM) devices.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.

The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.

Implantable Cardiac Rhythm Management Devices Market Report Highlights:

  • The hospital's end-use segment captured the largest revenue share of over 50.0% in 2021. The growth can be attributed to deeper product penetration, a large volume of surgical procedures, and rising patient footfall
  • The ICDs product segment held the largest revenue share of over 45.0% in 2021. The cardiac resynchronization therapy devices segment is expected to register the fastest growth rate over the forecast period
  • An estimated 85.7 million Americans (i.e., almost 34% of the population) suffered from high blood pressure and hypertension due to stressful lifestyles. Almost 23.4 million American adults were diagnosed with diabetes in 2017, while an estimated additional 7.6 million American adults are undiagnosed diabetics. Globally, the prevalence of diabetes is expected to increase to 7.7% in 2030
  • The CRT product segment is anticipated to register the fastest growth rate over the forecast period due to the implementation of supportive legislative policies in developed countries and an increase in awareness and the number of training programs for use of the products
  • North America dominated the market with a revenue share of over 45.0% in 2021. This can be attributed to an increase in the incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and an increase in the number of training programs
  • Asia Pacific is expected to exhibit the fastest CAGR of 6.6% from 2022 to 2030 due to the higher prevalence of CVDs and rapidly aging population

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Product
    • 1.1.2 End Use
    • 1.1.3 Region
    • 1.1.4 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume price analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Implantable CRM Devices Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing incidence of cardiac disorders
      • 3.1.1.2 Favorable reimbursement policies
      • 3.1.1.3 Growing geriatric population base
      • 3.1.1.4 Growing adoption of sedentary lifestyle
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Stringent regulatory framework
  • 3.2 CRM Devices: Market Analysis Tools
    • 3.2.1 Industry Analysis - Porter's Five Force Analysis
    • 3.2.2 Pestle Analysis
    • 3.2.3 Major Deals And Strategic Alliances
    • 3.2.4 Cardiac Practices In the U.S.
    • 3.2.5 Number Of Cardiologist And Electrophysiologist In The U.S.
    • 3.2.6 Implantable Loop Recorders (Ilr)

Chapter 4 COVID-19 Impact Analysis

  • 4.1 COVID-19 Prevalence Analysis
  • 4.2. Current Impact & Future Scenario
  • 4.3. Impact on companies

Chapter 5 Implantable CRM Devices Market: Segment Analysis, by Product, 2017 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Product Type Market Share Analysis, 2021 & 2030
  • 5.3 Global Implantable CRM Devices Market, by Product, 2017 to 2030
  • 5.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030
    • 5.4.1 Pacemaker
      • 5.4.1.1 Pacemaker, 2017 - 2030 (USD Million)
    • 5.4.2 ICDs
      • 5.4.2.1 ICDs, 2017 - 2030 (USD Million)
    • 5.4.3 CRT
      • 5.4.3.1 CRT, 2017 - 2030 (USD Million)

Chapter 6 Implantable CRM Devices Market: Segment Analysis, By End Use, 2017 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 End-Use Type Market Share Analysis, 2017 to 2030
  • 6.3 Global CRM devices Market, by End Use, 2017 to 2030
  • 6.4 Market Size & Forecasts and Trend Analyses, 2017 to 2030
    • 6.4.1 Hospitals
      • 6.4.1.1 Hospitals Market, 2017 - 2030 (USD Million)
    • 6.4.2 Specialty Cardiac Centers
      • 6.4.2.1 Specialty Cardiac Centers, 2017 - 2030 (USD Million)
    • 6.4.3 Others
      • 6.4.3.1 Others, 2017 - 2030 (USD Million)

Chapter 7 Implantable CRM Devices Market: Regional Market Analysis, by Product, End Use 2017 - 2030 USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2017 to 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030
  • 7.5 North America
    • 7.5.1 North America Market Estimates And Forecast, By Country, 2017 - 2030 (USD Million)
    • 7.5.2 North America Implantable Crm Devices Market, By Product, 2017 - 2030 (USD Million)
    • 7.5.3 North America Implantable Crm Devices Market, By End Use, 2017 - 2030 (USD Million)
    • 7.5.4 U.S.
      • 7.5.4.1 U.S. implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.5.5 Canada
      • 7.5.5.1 Canada implantable CRM devices market, 2017 - 2030 (USD Million)
  • 7.6 Europe
    • 7.6.1 Europe Implantable Crm Devices Market, By Country, 2017 - 2030 (USD Million)
    • 7.6.2 Europe Implantable Crm Devices Market, By Product, 2017 - 2030 (USD Million)
    • 7.6.3 Europe Implantable Crm Devices Market, By End Use, 2017 - 2030 (USD Million)
    • 7.6.4 U.K.
      • 7.6.4.1 U.K. implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.6.5 Germany
      • 7.6.5.1 Germany CRM devices market, 2017 - 2030 (USD Million)
    • 7.6.6 France
      • 7.6.6.1 France implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.6.7 Italy
      • 7.6.7.1 Italy implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.6.8 Spain
      • 7.6.8.1 Spain implantable CRM devices market, 2017 - 2030 (USD Million)
  • 7.7 Asia Pacific
    • 7.7.1 Asia Pacific Implantable Crm Devices Market, By Country, 2017 - 2030 (USD Million)
    • 7.7.2 Asia Pacific Implantable Crm Devices Market, By Product, 2017 - 2030 (USD Million)
    • 7.7.3 Asia Pacific Implantable Crm Devices Market, By End Use, 2017 - 2030 (USD Million)
    • 7.7.4 JAPAN
      • 7.7.4.1 Japan implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.7.5 CHINA
      • 7.7.5.1 China implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.7.6 India
      • 7.7.6.1 India implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.7.7 Australia
      • 7.7.7.1 Australia implantable CRM devices market, 2017 - 2030 (USD Million)
  • 7.8 Latin America
    • 7.8.1 Latin America Implantable Crm Devices Market, By Country, 2017 - 2030 (USD Million)
    • 7.8.2 Latin America Implantable Crm Devices Market, By Product, 2017 - 2030 (USD Million)
    • 7.8.3 Latin America Implantable Crm Devices Market, By End Use, 2017 - 2030 (USD Million)
    • 7.8.4 Brazil
      • 7.8.4.1 Brazil CRM devices market, 2017 - 2030 (USD Million)
    • 7.8.5 Mexico
      • 7.8.5.1 Mexico CRM devices market, 2017 - 2030 (USD Million)
  • 7.9 MEA
    • 7.9.1 MEA Implantable Crm Devices Market, By Country 2017 - 2030 (USD MILLION)
    • 7.9.2 Mea Implantable Crm Devices Market, By Product, 2017 - 2030 (USD Million)
    • 7.9.3 Mea Implantable Crm Devices Market, By End Use, 2017 - 2030 (USD Million)
    • 7.9.4 South Africa
      • 7.9.4.1 South Africa implantable CRM devices market, 2017 - 2030 (USD Million)
    • 7.9.5 SAUDI ARABIA
      • 7.9.5.1 Saudi Arabia implantable CRM devices market, 2017 - 2030 (USD Million)

Chapter 8 Implantable Cardiac Rhythm Management Devices Market - Competitive Analysis

  • 8.1 Market Participant Categorization
    • 8.1.1. Company Market Position Analysis
    • 8.1.2. Synergy Analysis: Major Deals & Strategic Alliances
    • 8.1.3. Market Leaders
    • 8.1.4. Innovators
  • 8.2. List of Key Companies

Chapter 9 Implantable Cardiac Rhythm Management Devices Market - Company Profiles

  • 9.1 Stryker
    • 9.1.1 Company overview
    • 9.1.2 FINANCIAL PERFORMANCE
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic initiatives
  • 9.2 Schiller
    • 9.2.1 Company overview
    • 9.2.2 Financial performance
    • 9.2.3 Product benchmarking
    • 9.2.4 Strategic initiatives
  • 9.3 Medtronic
    • 9.3.1 Company overview
    • 9.3.2 Financial performance
    • 9.3.3 Product benchmarking
    • 9.3.4 Strategic initiatives
  • 9.4 Abbott
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 Boston Scientific Corporation
    • 9.5.1 Company overview
    • 9.5.2 Financial performance
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic initiatives
  • 9.6 Koninklijke Philips N.V.
    • 9.6.1 Company overview
    • 9.6.2 Financial performance
    • 9.6.3 Product benchmarking
    • 9.6.4 Strategic initiatives
  • 9.7 Zoll Medical Corporation
    • 9.7.1 Company overview
    • 9.7.2 Financial performance
    • 9.7.3 Product benchmarking
    • 9.7.4 Strategic initiatives
  • 9.8 Biotronik
    • 9.8.1 Company overview
    • 9.8.2 Financial performance
    • 9.8.3 Product benchmarking
    • 9.8.4 Strategic initiatives
  • 9.9 Nihon Kohden Corporation
    • 9.9.1 Company overview
    • 9.9.2 Financial performance
    • 9.9.3 Product benchmarking
    • 9.9.4 Strategic initiatives
  • 9.10 Microport Scientific Corporation
    • 9.10.1 Company overview
    • 9.10.2 Financial performance
    • 9.10.3 Product benchmarking
    • 9.10.4 Strategic initiatives